Study Methods
Details of the electrophoresis, immunoblotting techniques, and quantification of the patterns have been described previously. 13 In brief, hematoma samples were collected in a tube containing sodium citrate. After centrifugation, the supernatant was prepared for electrophoresis with 2% SDS. Polyacrylamide gel (5%) was used for electrophoresis, according to Laemmli's method. 10 After electrophoresis was performed, proteins were transferred from the gel to a nitrocellulose membrane by Western blotting. 9 Immunostaining of fibrinogen, fibrin monomer, and FDP was conducted using goat antiserum to human FDP-D and FDP-E, and peroxidaseconjugated rabbit antiserum to goat immunoglobulin G. Each band was compared with the previous description 4,11 for identification. The concentration of fibrinogen, fibrin monomer, and FDP fragments (Cx) was calculated as: Cx = (Dx Ϭ D total FDP ) ϫ C FDP, where Dx was the density of the objective band on the nitrocellulose membrane measured by densitometry, Dtotal FDP the sum of the densities of the FDP fragments, and C FDP the concentration quantified using the latex fixation method after fibrinogen had been removed from the sample.
The concentrations of fibrinogen, fibrin monomer, and D dimer were used as indicators of rebleeding, coagulation, and fibrinolysis, respectively (see Discussion). Data are presented as the mean ± standard error of the mean. Each value was assessed by one-way analysis of variance (ANOVA). Differences were regarded as statistically significant at p < 0.05. High-density hematoma types were excluded from the statistical analysis because of their rarity.
Results

Fibrinogen in Chronic SDH's
Fibrinogen, fibrin monomer, and FDP fragments were identified by Western blot analysis of the chronic SDH's using anti-FDP antibodies ( Fig. 3 left) ; densities of the bands were measured and calculated as shown in Fig. 3 right.
The average concentration of fibrinogen in the supernatant fluid of chronic SDH's was 9.8 Ϯ 1.4 mg/dl (mean Ϯ standard error of the mean), which was lower than normal values in peripheral blood ( Table 1 ). The value in the mixed-density hematomas was significantly higher (15.7 Ϯ 3.4 mg/dl) than that in the low-density hematomas (1.4 Ϯ 0.6 mg/dl), and the value in the layering hematomas (15.7 Ϯ 2.6 mg/dl) was significantly higher than that in both the isodense hematomas (6.9 Ϯ 1.1 mg/dl) and the lowdensity hematomas (p Ͻ 0.05) (Fig. 4) . These findings indicate that the recent rebleeding was extensive in mixed-density and layering hematomas and small in low-density hematomas. 
Fibrin Monomer in Chronic SDH's
The average concentration of fibrin monomer was 114 Ϯ 16 g/ml (Table 1) , which was far beyond the upper limit of normal values in peripheral blood. As indicated in Fig. 4 , the values in the mixed-density (175 Ϯ 40 g/ml) and layering types of hematoma (177 Ϯ 23 g/ml) were significantly higher than in low-density hematomas (18 Ϯ 8 g/ml, p Ͻ 0.05). The fibrin monomer value in isodense hematomas was 8 Ϯ 22 g/ml. These findings suggest that coagulative activity was high in mixed-density and layering types of hematomas and low in low-density hematomas.
D Dimer and FDP in Chronic SDH's
The average concentration of FDP in the 41 chronic SDH's was 1355 Ϯ 175 g/ml (Table 1) , which was far beyond the upper limit of normal values in peripheral blood, and varied widely from 16 to 4760 g/ml. According to the electrophoretic pattern, fragments of D dimer could be distinguished from fragments of FgDP. The average concentration of D dimer was 1220 Ϯ 159 g/ml, which was higher than that in peripheral blood. The D dimer value in the layering type of hematoma (2032 Ϯ 384 g/ml) was significantly higher than in the low-density type of hematoma (301 Ϯ 164 g/ml). The values in isodense (1310 Ϯ 256 g/ml) and mixed-density (1039 Ϯ 207 g/ml) hematomas tended to be lower than in the layering type of hematoma (Fig. 4) . The average percentage of D dimer to total FDP was 88.1% Ϯ 0.8%. No correlation was observed between the ratio of D dimer to FgDP and the CT appearance. These findings indicate that fibrinolytic activity was high in the layering hematoma, moderate in the isodense and mixeddensity hematomas, and low in the low-density hematoma.
Discussion
Parameters of Rebleeding, Coagulation, and Fibrinolysis
The cycle of rebleeding, coagulation, and fibrinolysis has contributed to the development and maintenance of chronic SDH. 5 The use of SDS-PAGE with immunoblotting has made analysis of the details of these events possible by identifying fibrinogen and its derivatives. Three parameters were selected: fibrinogen as an indicator for recent rebleeding; fibrin monomer as an indicator for coagulative activity; and D dimer as an indicator for fibrinolytic activity. A high concentration of fibrinogen in chronic SDH's is evidence of continuous rebleeding, because fibrinogen is introduced into the cavity of the hematoma only by repeated bleeding and should disappear immediately through the action of thrombin changing it into fibrin. Fibrin monomer and D dimer, as indicators of coagulative activity 15 and fibrinolytic activity, 1 respectively, have already been accepted and used in the diagnosis of disseminated intravascular coagulation.
Appearance on CT and Electrophoretic Pattern
The relationship between the appearance of the hematoma on CT and its electrophoretic pattern was examined. Each group of CT scans was characterized in relation to rebleeding and coagulative and fibrinolytic activities.
In the layering type of chronic SDH, a large amount of recent rebleeding had occurred and coagulative and fibrinolytic activities were high. Kao 8 reported that the layering type of hematoma may be remarkable for a significant amount of rebleeding and may herald acute clinical deterioration. Saito, et al., 14 stated that, in layering hematomas, the plasmin-␣ 2 -plasmin inhibitor complex was higher than in any other type of chronic SDH. These results agree with ours. The hyperfibrinolytic activity seems to cause frequent, copious rebleeding, leading to severe signs and symptoms.
Mixed-density hematomas exhibit a large amount of recent rebleeding and high coagulative and low fibrinolytic activity. Ito, et al., 7 suggested that mixedand high-density hematomas indicate recent rebleeding, because clots or sediments obtained from the hematomas included many 51 Cr-labeled erythrocytes administered intravenously. The amount of recent rebleeding could be estimated from the concentration of fibrinogen. Mixed-density hematomas show much recent rebleeding despite a lower fibrinolytic activity than in the layering type. The tendency to rebleed is determined not only by the balance between coagulation and fibrinolysis, but also by other factors, such as vulnerability of the capillaries in the outer membrane, intracranial pressure, and blood pressure. Blood clots were frequently found during surgery in the higherdensity part of the mixed hematomas. Coagulation activity may be high enough relative to fibrinolysis to form fibrin in these hematomas.
In low-density hematomas, the tendency to rebleed and for coagulative and fibrinolytic activities were all moderately low. Nakamura, et al., 12 reported that every chronic SDH that resolved without surgery showed low density on follow-up CT. These authors also indicated that the fibrinolytic activity of lowdensity hematomas decreased with regression of the thickness of the cavity. Their findings support our results.
Isodense hematomas were seen most frequently in this series of 41 chronic SDH's. The parameters for rebleeding and coagulative and fibrinolytic activities showed higher values than those of the low-density type but lower than those of the layering type. Fujioka, et al., 2 reported that isodensity appeared in the later phase, following high-or low-density, and did not resolve naturally. Isodense hematomas seem to neither improve nor worsen, because rebleeding is moderate and the balance between coagulative and fibrinolytic activities is maintained.
